Zaheer Ul‐Haq

5.9k total citations
303 papers, 4.7k citations indexed

About

Zaheer Ul‐Haq is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Zaheer Ul‐Haq has authored 303 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Molecular Biology, 122 papers in Organic Chemistry and 89 papers in Computational Theory and Mathematics. Recurrent topics in Zaheer Ul‐Haq's work include Computational Drug Discovery Methods (89 papers), Synthesis and biological activity (74 papers) and Cholinesterase and Neurodegenerative Diseases (35 papers). Zaheer Ul‐Haq is often cited by papers focused on Computational Drug Discovery Methods (89 papers), Synthesis and biological activity (74 papers) and Cholinesterase and Neurodegenerative Diseases (35 papers). Zaheer Ul‐Haq collaborates with scholars based in Pakistan, Saudi Arabia and United States. Zaheer Ul‐Haq's co-authors include M. Iqbal Choudhary, Reaz Uddin, Sajda Ashraf, Abdul Wadood, Komal Zia, Atta‐ur Rahman, Ruqaiya Khalil, Salman Ali Khan, Khalid Mohammed Khan and Assem Barakat and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Physical Chemistry B.

In The Last Decade

Zaheer Ul‐Haq

278 papers receiving 4.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zaheer Ul‐Haq Pakistan 34 2.0k 1.6k 923 716 413 303 4.7k
Ahmed A. Al‐Karmalawy Egypt 47 2.5k 1.2× 2.0k 1.3× 1.1k 1.2× 394 0.6× 338 0.8× 200 5.6k
Priyanka Banerjee Germany 18 978 0.5× 1.6k 1.0× 1.7k 1.8× 618 0.9× 446 1.1× 37 4.3k
Harun Patel India 41 3.2k 1.6× 1.9k 1.2× 931 1.0× 495 0.7× 328 0.8× 241 5.6k
Feroz Khan India 38 1.1k 0.6× 1.7k 1.1× 608 0.7× 447 0.6× 563 1.4× 203 4.0k
Katharigatta N. Venugopala South Africa 39 2.6k 1.3× 1.5k 1.0× 391 0.4× 585 0.8× 498 1.2× 266 5.8k
Md Tabish Rehman Saudi Arabia 43 932 0.5× 2.3k 1.5× 834 0.9× 580 0.8× 810 2.0× 181 5.8k
Alexey A. Lagunin Russia 35 2.0k 1.0× 2.2k 1.4× 2.2k 2.4× 837 1.2× 401 1.0× 144 5.6k
Mohamed F. Alajmi Saudi Arabia 45 1.1k 0.5× 2.6k 1.6× 921 1.0× 585 0.8× 1.1k 2.6× 280 6.9k
Diogo Santos‐Martins United States 16 1.0k 0.5× 2.7k 1.7× 1.1k 1.2× 474 0.7× 315 0.8× 30 5.0k
Hai‐Bin Luo China 38 1.2k 0.6× 3.4k 2.1× 752 0.8× 1.2k 1.7× 875 2.1× 217 6.9k

Countries citing papers authored by Zaheer Ul‐Haq

Since Specialization
Citations

This map shows the geographic impact of Zaheer Ul‐Haq's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zaheer Ul‐Haq with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zaheer Ul‐Haq more than expected).

Fields of papers citing papers by Zaheer Ul‐Haq

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zaheer Ul‐Haq. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zaheer Ul‐Haq. The network helps show where Zaheer Ul‐Haq may publish in the future.

Co-authorship network of co-authors of Zaheer Ul‐Haq

This figure shows the co-authorship network connecting the top 25 collaborators of Zaheer Ul‐Haq. A scholar is included among the top collaborators of Zaheer Ul‐Haq based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zaheer Ul‐Haq. Zaheer Ul‐Haq is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shafiq, Muhammad, et al.. (2025). Monolayered π-d conjugated metal-2,3,5,6-tetraamino-1,4-benzoquinone coordination polymers as potential cathode materials for Li-ion batteries. Journal of Energy Storage. 109. 115149–115149. 1 indexed citations
3.
Nur‐e‐Alam, Mohammad, et al.. (2024). Strain−free 2D h−B2S3 nano−electrocatalyst for efficient hydrogen evolution reaction: An ab initio study. International Journal of Hydrogen Energy. 98. 448–453. 2 indexed citations
4.
Nur‐e‐Alam, Mohammad, et al.. (2024). Exploring the ultra-high hydrogen storage capacity of Li-decorated h-B2S3 nanosheet: A DFT-D3 study. Journal of Energy Storage. 106. 114915–114915. 8 indexed citations
5.
Jabeen, Almas, et al.. (2024). Oxadiazole Derivatives of Diclofenac as an Anti-proliferative Agent forB-cell Non-Hodgkin Lymphoma: An In vitro and In Silico Studies. Medicinal Chemistry. 20(4). 443–451. 2 indexed citations
6.
Ansari, Saqib Hussain, et al.. (2024). Molecular pathology and computational profiling of Janus kinase 2 (JAK2) mutation in acute lymphoblastic leukemia: insights from a Pakistani cohort. Laboratory Medicine. 56(2). 136–145. 1 indexed citations
8.
Shafiq, Muhammad, et al.. (2024). Uncovering PPAR-γ agonists: An integrated computational approach driven by machine learning. Journal of Molecular Graphics and Modelling. 129. 108742–108742. 3 indexed citations
9.
Saleem, Faiza, Khalid Mohammed Khan, Musa Özil, et al.. (2023). Regioselective syntheses of 2-oxopyridine carbonitrile derivatives and evaluation for antihyperglycemic and antioxidant potential. International Journal of Biological Macromolecules. 241. 124589–124589. 13 indexed citations
10.
Barakat, Assem, Abdullah Mohammed Al‐Majid, Matti Haukka, et al.. (2023). New spiro-indeno[1,2- b ]quinoxalines clubbed with benzimidazole scaffold as CDK2 inhibitors for halting non-small cell lung cancer; stereoselective synthesis, molecular dynamics and structural insights. Journal of Enzyme Inhibition and Medicinal Chemistry. 38(1). 2281260–2281260. 10 indexed citations
11.
Ashraf, Sajda, et al.. (2023). Unraveling the versatility of human serum albumin – A comprehensive review of its biological significance and therapeutic potential. SHILAP Revista de lepidopterología. 6. 100114–100114. 26 indexed citations
12.
Ul‐Haq, Zaheer, et al.. (2023). Highlights in TMPRSS2 inhibition mechanism with guanidine derivatives approved drugs for COVID-19 treatment. Journal of Biomolecular Structure and Dynamics. 41(22). 12908–12922. 4 indexed citations
13.
Al‐Majid, Abdullah Mohammed, M. Ali, Marwa M. Abu‐Serie, et al.. (2023). Rational Design, Synthesis, Separation, and Characterization of New Spiroxindoles Combined with Benzimidazole Scaffold as an MDM2 Inhibitor. Separations. 10(4). 225–225. 8 indexed citations
14.
Shahab, Muhammad, et al.. (2022). Design of a novel multiple epitope-based vaccine: an immunoinformatics approach to combat monkeypox. Journal of Biomolecular Structure and Dynamics. 41(19). 9344–9355. 23 indexed citations
15.
Ul‐Haq, Zaheer, et al.. (2022). Structure-Based Discovery of Potent Staphylococcus aureus Thymidylate Kinase Inhibitors by Virtual Screening. Medicinal Chemistry. 19(1). 75–90. 5 indexed citations
16.
Khan, Salman Ali, et al.. (2022). Deciphering the Impact of Mutations on the Binding Efficacy of SARS-CoV-2 Omicron and Delta Variants With Human ACE2 Receptor. Frontiers in Chemistry. 10. 892093–892093. 16 indexed citations
17.
18.
Mughal, Ehsan Ullah, Komal Zia, Amina Sadiq, et al.. (2020). Synthetic flavonoids as potential antiviral agents against SARS-CoV-2 main protease. Journal of Biomolecular Structure and Dynamics. 40(8). 3777–3788. 24 indexed citations
20.
Khan, Saifullah, Azizuddin, Sobia Ahsan Halim, et al.. (2013). In-vitro immunomodulatory and anti-cancerous activities of biotransformed products of Dianabol through Azadirachta indica and its molecular docking studies. Chemistry Central Journal. 7(1). 163–163. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026